Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000263675 | SCV000387124 | benign | GTP cyclohydrolase I deficiency | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000430107 | SCV000510805 | likely benign | not provided | 2016-08-04 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Laboratory for Molecular Medicine, |
RCV000455719 | SCV000539228 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Reported in 1 individual with dystonia in trans with a nonsense variant (Jarman 1997). In a family with 2 members, it was identified in 2 affected individuals with DOPA-responsive dystonia and 1 with Parkinsons, this variant was identified in 1 individual with dystonia and 1 with Parkinsons (who also had a Phe104Leu variant) (Mencacci 2014). One of the family members with dystonia only had the Phe104Leu variant. This variant was described as benign due to its MAF. MAF 1.5% in Eur chr. |
Ce |
RCV000430107 | SCV000608703 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | GCH1: BS2 |
Labcorp Genetics |
RCV001084264 | SCV000631822 | benign | Dystonia 5; GTP cyclohydrolase I deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000430107 | SCV000842148 | benign | not provided | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000263675 | SCV001139463 | benign | GTP cyclohydrolase I deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001111087 | SCV001268594 | benign | Dystonia 5 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Elsea Laboratory, |
RCV001084264 | SCV001424236 | uncertain significance | Dystonia 5; GTP cyclohydrolase I deficiency | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000430107 | SCV001872141 | benign | not provided | 2018-12-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31213404, 30314816, 25497597, 9328244, 19332422, 24993959) |
Diagnostic Laboratory, |
RCV000430107 | SCV001739888 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000430107 | SCV001800529 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000430107 | SCV001922547 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003940216 | SCV004748440 | likely benign | GCH1-related disorder | 2020-10-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |